CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 117 enrolled
Drug / intervention
Basivertebral Nerve (BVN) Ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03997825
NCT03997825N/ACompleted
CompareCT.gov

Five-Plus Year Follow-Up of SMART (Surgical Multicenter Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain) Trial

Relievant Medsystems, Inc.·observational·Posted Jun 25, 2019·Updated Jan 13, 2021

In Brief

An observational study evaluating Basivertebral Nerve (BVN) Ablation for Chronic Low Back Pain. Completed, enrolled 117 participants across 13 sites.

Detailed Summary

The objective of this study is to evaluate long-term ongoing effectiveness of the Intracept Intraosseous Nerve Ablation System for the treatment of chronic low back pain.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Low Back Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 25, 2019
Enrollment StartJun 13, 2019
Primary CompletionNov 8, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.0 years ago

Interventions

Basivertebral Nerve (BVN) Ablationdevice

Single follow-up visit of previously treated participants from the SMART trial.